ADC Therapeutics SA said it issued warrants to entities managed by HealthCare Royalty Management, LLC in an unregistered transaction tied to an amendment of its existing royalty financing agreement. The warrants allow the purchase of 9,834,776 common shares at an exercise price of $3.8130 per share and are exercisable until Dec. 31, 2030, with certain transfer restrictions until Dec. 31, 2027. The company also agreed to file a resale registration statement for the underlying shares within 30 business days.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ADC Therapeutics SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950103-26-002466), on February 23, 2026, and is solely responsible for the information contained therein.